The company has setup a state-of-the-art genomics lab at Dubai Science Park
4baseCare has launched operations in Dubai by establishing a genomics lab at Dubai Science Park, in collaboration with Innovate Life Sciences.
This expansion is in line with 4baseCare’s strategic plan to strengthen its footprint across Southeast Asia and the Middle East. The recent $6 million fund raise from Yali Capital has played a pivotal role in fueling this growth and paving the way for further expansion across other international geographies.
The new genomics lab will provide genomic testing solutions, including comprehensive cancer gene panels, whole exome sequencing, and transcriptome analysis. These advanced tools will enable oncologists to delve deeper into the genetic makeup of tumors, offering personalised and more effective treatment options.
“Genomics is essential to unlock life-changing therapies, and 4baseCare’s partnership with Innovate Life Sciences, one of more than 500 industry leaders at Dubai Science Park, is a pivotal step in harnessing its potential,” said Marwan Abdulaziz Janahi, Senior Vice President of Dubai Science Park at TECOM Group.
“As the address of collaborations such as Innovate Life Sciences with 4baseCare, Dubai Science Park’s community is enabling healthcare advancements to benefit patients, in line with the goals of Dubai Research and Development Programme and Dubai Economic Agenda ‘D33’.”
Hitesh Goswami, CEO of 4baseCare, said, “Cancer touches us all—our families, our friends, our communities. The global burden of this disease continues to grow, and we cannot wait any longer to act. Through this partnership, we are bringing hope to cancer patients across the Middle East. We are committed to ensuring that advanced, personalized cancer care is within reach for everyone who needs it.”
“Our new partnership at Dubai Science Park is a collaborative effort to manage the economic burden of cancer and expand access to cancer care. The rising costs of controlling cancer is an undeniable challenge for the ME region. The long-term sustainability of oncology care will require the collaboration of various stakeholders. With this partnership, we are fully committed to helping clinicians and patients in the Middle East access the best that precision oncology has to offer,” Hitesh added.
4baseCare also unveiled SoLiq- A solid-liquid NGS tests portfolio that combines the best of both worlds—solid and liquid biopsy technologies—to give oncologists a 360° view of tumor biology.